Sanctuary Advisors LLC Has $525,000 Stake in Surgery Partners, Inc. (NASDAQ:SGRY)

Sanctuary Advisors LLC boosted its position in Surgery Partners, Inc. (NASDAQ:SGRY) by 27.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 24,778 shares of the company’s stock after buying an additional 5,351 shares during the quarter. Sanctuary Advisors LLC’s holdings in Surgery Partners were worth $525,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of SGRY. KBC Group NV grew its stake in Surgery Partners by 31.8% in the 3rd quarter. KBC Group NV now owns 2,385 shares of the company’s stock valued at $77,000 after buying an additional 576 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. grew its stake in Surgery Partners by 747.6% in the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company’s stock valued at $124,000 after buying an additional 3,379 shares during the last quarter. MeadowBrook Investment Advisors LLC grew its holdings in Surgery Partners by 16.6% in the 4th quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company’s stock valued at $218,000 after buying an additional 1,460 shares during the last quarter. Empowered Funds LLC acquired a new stake in Surgery Partners in the 4th quarter valued at approximately $245,000. Finally, Creative Planning acquired a new stake in Surgery Partners in the 3rd quarter valued at approximately $258,000.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. Royal Bank of Canada lowered their target price on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating on the stock in a report on Wednesday, November 20th. JPMorgan Chase & Co. decreased their price target on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating on the stock in a research report on Tuesday, December 3rd. Bank of America initiated coverage on shares of Surgery Partners in a research report on Monday, December 16th. They issued a “buy” rating and a $30.00 price target on the stock. Finally, Macquarie restated an “outperform” rating and issued a $34.00 price target on shares of Surgery Partners in a research report on Tuesday, November 19th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $36.56.

Surgery Partners Price Performance

Shares of Surgery Partners stock opened at $24.08 on Friday. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. The firm’s 50-day simple moving average is $23.04 and its 200-day simple moving average is $26.49. Surgery Partners, Inc. has a twelve month low of $19.50 and a twelve month high of $33.97. The firm has a market cap of $3.06 billion, a P/E ratio of -50.17, a price-to-earnings-growth ratio of 19.21 and a beta of 2.60.

Insider Activity

In related news, CFO David T. Doherty sold 13,641 shares of the business’s stock in a transaction on Friday, February 7th. The stock was sold at an average price of $25.61, for a total value of $349,346.01. Following the sale, the chief financial officer now owns 108,862 shares of the company’s stock, valued at $2,787,955.82. The trade was a 11.14 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Harrison R. Bane sold 56,315 shares of the business’s stock in a transaction on Friday, February 7th. The shares were sold at an average price of $25.64, for a total value of $1,443,916.60. Following the completion of the sale, the insider now directly owns 107,037 shares in the company, valued at approximately $2,744,428.68. This represents a 34.47 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 96,733 shares of company stock worth $2,480,106. Corporate insiders own 2.30% of the company’s stock.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.